FORM vs GSK · P/E 143, rev $484.4M vs P/E 13, $103.31B cap
FormFactor Inc (FORM) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
FormFactor Inc (FORM) is a semiconductor equipment & materials company listed on US.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported FORM revenue for 2026-06-27 was $484.4M. Net income was $76.6M. FORM currently screens at market cap $9.71B and trailing P/E 143.2.
GSK does not have a complete income-statement cache yet.
FORM currently screens at market cap $9.71B and trailing P/E 143.2. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the FORM and GSK stock pages for the full models.
Not investment advice.